Smartphone-based in vitro diagnostic technologies for personalized healthcare monitoring and management

2016 ◽  
pp. 231-251 ◽  
Author(s):  
Vashist ◽  
von Stetten ◽  
Luong ◽  
Venkatesh ◽  
Zengerle
Keyword(s):  
Personalized Healthcare ◽  
In Vitro Diagnostic ◽  
Healthcare Monitoring ◽  
Diagnostic Technologies

scholarly journals A parallel revolution: payment for new in vitro diagnostic technologies

1996 ◽  
Vol 42 (9) ◽  
pp. 1558-1560
Author(s):  
L P Ivor
Keyword(s):  
Life Cycle ◽  
Clinical Outcomes ◽  
Cost Containment ◽  
Driving Force ◽  
Continuous Monitoring ◽  
Business Plan ◽  
Market Forces ◽  
In Vitro Diagnostic ◽  
Diagnostic Technologies

Abstract To secure a successful product in today's era of cost containment, manufacturers and developers of new in vitro diagnostic technologies must consider payment issues--coverage and reimbursement by healthcare insurers--as critical market forces that must be addressed in the business plan. Similar to the regulatory hurdles involving 510(k)s and premarket applications, the requirements for payment are related to the unique features of the technology, its costs, and its effect on clinical outcomes. Because cost containment continues to be a driving force for change in healthcare, the business plan must not only include strategies for optimal payment at the product's introduction, but also contain provisions for continuous monitoring of the payment environment throughout the product's life cycle.

Low-cost In Vitro Diagnostic Technologies

2015 ◽  
pp. 59-91 ◽  
Author(s):  
Chao-Min Cheng ◽  
Chen-Meng Kuan ◽  
Chien-Fu Chen
Keyword(s):  
Low Cost ◽  
In Vitro Diagnostic ◽  
Diagnostic Technologies
Sign in / Sign up

Export Citation Format

Share Document